Streptococcus pneumoniae serotype distribution in Bangladeshi under-fives with community-acquired pneumonia pre-10-valent pneumococcal conjugate vaccination
In almost a third of the studied cases S. pneumoniae was identified as a causative pathogen. Because of the characteristics of the immunoassay, this might well be a gross underestimation. Nevertheless, the potential PCV10-coverage was low. Given the high serotype diversity, the region might benefit greatly from a higher-coverage PCV or recombinant protein vaccine.
Authors
- Tariq A. Lalmahomed (ORCID: https://orcid.org/0000-0002-9007-5713)
- Ger T. Rijkers (ORCID: https://orcid.org/0000-0001-6948-6123)
- Dilruba Ahmed (ORCID: https://orcid.org/0000-0001-8961-2406)
- Doli Goswami (ORCID: https://orcid.org/0000-0002-7106-8315)
- Hubert P. Endtz (ORCID: https://orcid.org/0000-0002-1018-0864)
- Stefan M.T. Vestjens
- Bob Meek (ORCID: https://orcid.org/0000-0003-3410-9912)
- Bart J. M. Vlaminckx
- Ben de Jong
- Suzan P. van Mens
- Bartelt M. de Jongh
- W. Abdullah Brooks
Institutions
- Johns Hopkins University (US)
- International Centre for Diarrhoeal Disease Research (BD)
- Roosevelt Institute for American Studies (NL)
- Maastricht University Medical Centre (NL)
- Erasmus MC (NL)
- St. Antonius Ziekenhuis (NL)
- Diakonessenhuis hospital (NL)
Publication Details
- Journal
- Pneumonia
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1186/s41479-024-00152-w
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Sanofi
- Sanofi Pasteur